#25: Regulatory Considerations for Drug Development: Current Status and Trend of IND/NDA Practice in China
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine (PIM) and DIA. PIM is accredited by the ACCME to provide continuing medical education for physicians.
PIM designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 3.25 contact hours or .325 continuing education units (CEU’s).Type of Activity: Knowledge 0286-0000-17-507-L04-PACPE Credit Requests MUST BE SUBMITTED by Wednesday, August 9, 2017. DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity (by Wednesday, August 10, 2016). Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit Obtain your NABP e-Profile.
This educational activity for 3.25 contact hours is provided by Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to .3 CEUs for this program. Participants must attend the entire program (and tutorial(s) if applicable) in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
Certificate Program StatementThis program is part of DIA’s Certificate Program and is awarded the following:
- Regulatory Affairs Certificate Program: 2 Elective Units
To view DIA’s Grievance Policy, visit DIAglobal.org/CE
|Name||Credit Type||Max Credits||CEU|
|#25: Regulatory Considerations for Drug Developmen||Credit TypeACPE||Max Credits3.25||CEU0.325|
|#25: Regulatory Considerations for Drug Developmen||Credit TypeCME||Max Credits3.25||CEU0.000|
|#25: Regulatory Considerations for Drug Developmen||Credit TypeIACET||Max Credits3.25||CEU0.300|
|#25: Regulatory Considerations for Drug Developmen||Credit TypeRN||Max Credits3.25||CEU0.000|
Statement of Credit:
To access My Transcript:
- Visit DIAglobal.org, select “Sign in” and you will be prompted for your user ID and password
- Choose MENU, found in the upper left corner
- Under CONFERENCES select “Continuing Education"
- Select the blue “My Transcript” button followed by “Credit Request” to process your credit request for the short course